Mindchild has entered into a strategic partnership with Henry Schein
April 2018 – England & Company served as the financial and strategic advisor to MindChild Medical, Inc., (“MindChild”) in the signing of an exclusive distribution and supply agreement for the MERIDIAN™ M110 Fetal Monitoring System with Henry Schein, Inc.(NASDAQ: HSIC), (“Henry Shein”) a leading FORTUNE 500 global healthcare products and solutions company.
The MERIDIAN M110, currently available to Henry Schein customers, is an intrapartum fetal monitor that externally measures and displays fetal heart rate (FHR), maternal heart rate (MHR), and uterine contractions (UA). As part of the agreement, Henry Schein Medical will distribute the monitor to its obstetricians and pediatric cardiologist customers in the U.S.
Adam Wolfberg, M.D., Chief Medical Officer, MindChild stated, “The ability to monitor accurate fetal heart rate by extracting ECG information while simultaneously monitoring maternal heart rate, as well as uterine contraction, is a tremendous achievement. As the MERIDIAN M110 enters the labor and delivery market, new diagnostic capabilities will undoubtedly emerge, providing insight into fetal management not currently available.”
Dr. Wolfberg continued, “In the coming months and years, MindChild will build on this technology to improve the safety of obstetrics, and provide a new diagnostic device to obstetricians and pediatric cardiologists.”